RxDoctor Payments Data

Jordan Dehaven, DPM

Foot & Ankle Surgery · Bristol, RINPI 1750510988

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,909 of the $4,109 with a category attached, or 70.8%. 21 manufacturers reported payments, led by Kairos Surgical Inc at 29.6% of the total. Reporting peaked in 2021 at $1,503 and has fallen 74.2% since, to $388 in 2025.

$4,109in general payments, 2019–2025

Across 56 payments — averaging $73.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$1K
  • Smith+Nephew$902
  • Medtronic$561
  • Stryker$358
  • Orthofix Medical, Inc.$161
  • Zimmer Biomet$138
  • plus $775 from 15 others

What the payments were for

  • Food & beverage$2,90971%
  • Education$1,20029%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,109 in reported general payments places this provider in the 55th percentile of 58 foot & ankle surgery providers in Rhode Island.

See all foot & ankle surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$173,932
Medicare patients
567
Services billed
3,115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole31$919
Gabapentin81$899
Terbinafine Hcl37$751
Colchicine28$709
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$664
Allopurinol37$370
Naproxen53$315
Ammonium Lactate11$312
Pregabalin20$309
Meloxicam37$233
Doxycycline Hyclate28$222
Mupirocin18$91
Prednisone32$81

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Bristol

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →